11th MAGNETOM World SummitListen – Discuss – Share

Missed the live stream? Watch the recordings of the 11th MAGNETOM World Summit!

DENSE Trial - Implications for Breast Cancer Screening

Carla van Gils (University Medical Center, UMC Utrecht, The Netherlands)

Repetitive HR-MRI of the Breast at Intervals of Maximum 24 Months - a Way to Reduce Mortality ?

Uwe Fischer (Diagnostisches Brustzentrum Göttingen, BZG, Göttingen, Germany)

Further Reading: Short first-pass MRI of the beast (pdf) 0.68 MB
Further Reading: HR-MRI of the Breast at Intervals of Maximum 24 Months: Influence on Tumor Stage at the Time of Diagnosis (pdf) 2.52 MB

Implementing Abbreviated MRI Screening into a Breast Imaging Practice

Donna Plecha (Univ Hospitals Cleveland, USA)

Abbreviated Breast MRI. The Royal Melbourne Journey

Angela Agostinelli (The Royal Melbourne Hospital, Parkville Victoria, Australia)

Treatment Response Assessment with MRI

Susan Weinstein (Penn Medicine, University of Pennsylvania Health System, Philadelphia, PA, USA)

Further Reading
Susan P. Weinstein, Katrina Korhonen, Claire Cirelli, Mitchell D. Schnall, Elizabeth S. McDonald, Austin R. Pantel, Samantha Zuckerman, Ari Borthakur, Emily F. Conant. Abbreviated Breast Magnetic Resonance Imaging for Supplemental Screening of Women With Dense Breasts and Average Risk. J Clin Oncol 38, September 15, 2020: DOI
https://doi.org/10.1200/JCO.19.02198.

MRI in Breast Cancer: From Bench to Bedside & Beyond. MRI-derived Parameters for Hormone Receptors

Katja Pinker-Domenig (Memorial Sloan-Kettering Cancer Center, New York, NY, USA)

Did this information help you?

The statements by Siemens Healthineers customers described herein are based on results that were achieved in the customer’s unique setting. Since there is no “typical” hospital and many variables exist (e.g., hospital size, case mix, level of IT adoption) there can be no guarantee that other customers will achieve the same results.